416 related articles for article (PubMed ID: 24081208)
21. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
[TBL] [Abstract][Full Text] [Related]
22. Validation of limited sampling strategy for the estimation of mycophenolic acid exposure in Chinese adult liver transplant recipients.
Hao C; Erzheng C; Anwei M; Zhicheng Y; Baiyong S; Xiaxing D; Weixia Z; Chenghong P; Hongwei L
Liver Transpl; 2007 Dec; 13(12):1684-93. PubMed ID: 18044788
[TBL] [Abstract][Full Text] [Related]
23. Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.
Miura M; Satoh S; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Suzuki T
Ther Drug Monit; 2008 Feb; 30(1):52-9. PubMed ID: 18223463
[TBL] [Abstract][Full Text] [Related]
24. [Prediction of mycophenolic acid exposure in renal transplantation recipients by artificial neural network].
Ren B; He QY; Xu Q; Wang CX; Chen J; Zheng ZH; Li SX; Chen X
Yao Xue Xue Bao; 2009 Dec; 44(12):1397-401. PubMed ID: 21351476
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P
Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients.
Barraclough KA; Isbel NM; Franklin ME; Lee KJ; Taylor PJ; Campbell SB; Petchey WG; Staatz CE
Ther Drug Monit; 2010 Dec; 32(6):723-33. PubMed ID: 21068647
[TBL] [Abstract][Full Text] [Related]
27. Generation and Validation of a Limited Sampling Strategy to Monitor Mycophenolic Acid Exposure in Children With Nephrotic Syndrome.
Benz MR; Ehren R; Kleinert D; Müller C; Gellermann J; Fehrenbach H; Schmidt H; Weber LT
Ther Drug Monit; 2019 Dec; 41(6):696-702. PubMed ID: 31425441
[TBL] [Abstract][Full Text] [Related]
28. A clinical assessment of mycophenolate drug monitoring after liver transplantation.
Hwang S; Lee SG; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Choi NK; Kim KW; Yu YD; Park GC; Park PJ; Choi YI
Clin Transplant; 2010; 24(2):E35-42. PubMed ID: 20070319
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: a abbreviated sampling strategy.
Muller H; Solari S; Zuniga C; Guerra I; Troncoso J; Ovalle R; Morente J; Pedreros C
Transplant Proc; 2007 Apr; 39(3):596-9. PubMed ID: 17445553
[TBL] [Abstract][Full Text] [Related]
30. Limited sampling strategy for predicting area under the concentration-time curve for mycophenolic Acid in Chinese adults receiving mycophenolate mofetil and tacrolimus early after renal transplantation.
Cai W; Ye C; Sun X; Qin K; Qin Y; Zhao D; Wu F; Hu Y; Li H; Tan L
Ther Drug Monit; 2015 Jun; 37(3):304-10. PubMed ID: 25525761
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
Poulin E; Greanya ED; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
Ther Drug Monit; 2011 Feb; 33(1):50-5. PubMed ID: 21157401
[TBL] [Abstract][Full Text] [Related]
32. Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.
Weber LT; Hoecker B; Armstrong VW; Oellerich M; Tönshoff B
Ther Drug Monit; 2006 Oct; 28(5):623-31. PubMed ID: 17038876
[TBL] [Abstract][Full Text] [Related]
33. Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation.
Baraldo M; Cojutti PG; Isola M; Feruglio MT; Tursi V; Livi U; Furlanut M
Transplant Proc; 2009 Dec; 41(10):4277-84. PubMed ID: 20005384
[TBL] [Abstract][Full Text] [Related]
34. Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients.
Aw MM; Brown NW; Itsuka T; Gonde CE; Adams JE; Heaton ND; Tredger JM; Mieli-Vergani G; Dhawan A
Liver Transpl; 2003 Apr; 9(4):383-8. PubMed ID: 12682891
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function.
Pape L; Ehrich JH; Offner G
Clin Transplant; 2004 Oct; 18(5):576-9. PubMed ID: 15344963
[TBL] [Abstract][Full Text] [Related]
37. Evalutation of mycophenolic acid systemic exposure by limited sampling strategy in kidney transplant recipients receiving enteric-coated mycophenolate sodium (EC-MPS) and cyclosporine.
Capone D; Tarantino G; Kadilli I; Polichetti G; Basile V; Federico S; Sabbatini M
Nephrol Dial Transplant; 2011 Sep; 26(9):3019-25. PubMed ID: 21317409
[TBL] [Abstract][Full Text] [Related]
38. Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients.
Cai W; Cai Q; Xiong N; Qin Y; Lai L; Sun X; Hu Y
Transplant Proc; 2018 Jun; 50(5):1298-1304. PubMed ID: 29735215
[TBL] [Abstract][Full Text] [Related]
39. Correlation between mycophenolic acid blood level and renal dysfunction in stable liver transplant recipients receiving mycophenolate monotherapy.
Park YH; Hwang S; Song GW; Jung DH; Ahn CS; Kim KH; Moon DB; Ha TY; Park GC; Kim N; Lee SG
Transplant Proc; 2014 Apr; 46(3):811-5. PubMed ID: 24767354
[TBL] [Abstract][Full Text] [Related]
40. Population pharmacokinetics of mycophenolic acid in renal transplant recipients.
van Hest RM; van Gelder T; Vulto AG; Mathot RA
Clin Pharmacokinet; 2005; 44(10):1083-96. PubMed ID: 16176120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
